Kolls Jay K
Department of Pediatrics, Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Ann Am Thorac Soc. 2014 Dec;11 Suppl 5(Suppl 5):S284-6. doi: 10.1513/AnnalsATS.201403-109AW.
The HIV epidemic has clearly demonstrated the critical role CD4(+) T cells play in preventing opportunistic infections in the lung. The types of CD4(+) effector T-cell populations in the lung have significantly expanded over the last 8-10 years with the discovery of helper T type 17 cells, and this review summarizes the field and discusses how these effector cells may be exploited to augment mucosal immunity in the lung.
艾滋病毒流行已清楚地表明CD4(+) T细胞在预防肺部机会性感染中所起的关键作用。随着辅助性T17细胞的发现,肺部CD4(+) 效应T细胞群体的类型在过去8至10年中显著扩大,本综述总结了该领域的情况,并讨论了如何利用这些效应细胞来增强肺部的黏膜免疫力。